115 related articles for article (PubMed ID: 22119742)
1. Albumin: a versatile carrier for drug delivery.
Park K
J Control Release; 2012 Jan; 157(1):3. PubMed ID: 22119742
[No Abstract] [Full Text] [Related]
2. Bioactive albumin-based carriers for tumour chemotherapy.
Shahzad Y; Khan IU; Hussain T; Alamgeer ; Serra CA; Rizvi SA; Gerber M; du Plessis J
Curr Cancer Drug Targets; 2014; 14(8):752-63. PubMed ID: 25348019
[TBL] [Abstract][Full Text] [Related]
3. Impact of albumin on drug delivery--new applications on the horizon.
Elsadek B; Kratz F
J Control Release; 2012 Jan; 157(1):4-28. PubMed ID: 21959118
[TBL] [Abstract][Full Text] [Related]
4. Protein-based nanoparticles for drug delivery purposes.
Martínez-López AL; Pangua C; Reboredo C; Campión R; Morales-Gracia J; Irache JM
Int J Pharm; 2020 May; 581():119289. PubMed ID: 32243968
[TBL] [Abstract][Full Text] [Related]
5. Targeting of the VEGF-kinase inhibitor PTK787 to angiogenic vasculature using RGD-equipped albumin carrier molecules.
Temming K; Lacombe M; Moorlag HE; Asgeirsdottir SA; Orfi L; Kéri G; Poelstra K; Molema G; Kok RJ
J Control Release; 2006 Nov; 116(2):e57. PubMed ID: 17718970
[No Abstract] [Full Text] [Related]
6. Making a case for albumin – a highly promising drug-delivery system.
Merlot AM; Kalinowski DS; Kovacevic Z; Jansson PJ; Lane DJ; Huang ML; Sahni S; Richardson DR
Future Med Chem; 2015; 7(5):553-6. PubMed ID: 25921396
[No Abstract] [Full Text] [Related]
7. Pharmaceutical Technology Innovation Strategy Based on the Function of Blood Transport Proteins as DDS Carriers for the Treatment of Intractable Disorders and Cancer.
Taguchi K
Biol Pharm Bull; 2020; 43(12):1815-1822. PubMed ID: 33268699
[TBL] [Abstract][Full Text] [Related]
8. Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate.
Stehle G; Wunder A; Schrenk HH; Hartung G; Heene DL; Sinn H
Anticancer Drugs; 1999 Sep; 10(8):785-90. PubMed ID: 10573211
[TBL] [Abstract][Full Text] [Related]
9. Albumin-based nanoparticles as potential controlled release drug delivery systems.
Elzoghby AO; Samy WM; Elgindy NA
J Control Release; 2012 Jan; 157(2):168-82. PubMed ID: 21839127
[TBL] [Abstract][Full Text] [Related]
10. Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review.
Van de Sande L; Cosyns S; Willaert W; Ceelen W
Drug Deliv; 2020 Dec; 27(1):40-53. PubMed ID: 31858848
[TBL] [Abstract][Full Text] [Related]
11. Targeting of nanoparticles in cancer: drug delivery and diagnostics.
Talekar M; Kendall J; Denny W; Garg S
Anticancer Drugs; 2011 Nov; 22(10):949-62. PubMed ID: 21970851
[TBL] [Abstract][Full Text] [Related]
12. Efficiency of drug delivery to the coronary arteries in swine is dependent on the route of administration: assessment of luminal, intimal, and adventitial coronary artery and venous delivery methods.
Karanian JW; Peregoy JA; Chiesa OA; Murray TL; Ahn C; Pritchard WF
J Vasc Interv Radiol; 2010 Oct; 21(10):1555-64. PubMed ID: 20813544
[TBL] [Abstract][Full Text] [Related]
13. Dermal peptide delivery using colloidal carrier systems.
Goebel A; Neubert RH
Skin Pharmacol Physiol; 2008; 21(1):3-9. PubMed ID: 17912018
[TBL] [Abstract][Full Text] [Related]
14. Seeing is believing--visualizing drug delivery in vitro and in vivo.
Swartz H
Adv Drug Deliv Rev; 2005 Jun; 57(8):1085-6. PubMed ID: 15935867
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles and microparticles for skin drug delivery.
Prow TW; Grice JE; Lin LL; Faye R; Butler M; Becker W; Wurm EM; Yoong C; Robertson TA; Soyer HP; Roberts MS
Adv Drug Deliv Rev; 2011 May; 63(6):470-91. PubMed ID: 21315122
[TBL] [Abstract][Full Text] [Related]
16. Acetals as pH-sensitive linkages for drug delivery.
Gillies ER; Goodwin AP; Fréchet JM
Bioconjug Chem; 2004; 15(6):1254-63. PubMed ID: 15546191
[TBL] [Abstract][Full Text] [Related]
17. Navigating albumin-based nanoparticles through various drug delivery routes.
Tan YL; Ho HK
Drug Discov Today; 2018 May; 23(5):1108-1114. PubMed ID: 29408437
[TBL] [Abstract][Full Text] [Related]
18. Albumin: the next-generation delivery technology.
Howard KA
Ther Deliv; 2015 Mar; 6(3):265-8. PubMed ID: 25853301
[No Abstract] [Full Text] [Related]
19. Is there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents?
Costantino L; Boraschi D
Drug Discov Today; 2012 Apr; 17(7-8):367-78. PubMed ID: 22094246
[TBL] [Abstract][Full Text] [Related]
20. A nanoscopic multivalent antigen-presenting carrier for sensitive detection and drug delivery to T cells.
Fahmy TM; Schneck JP; Saltzman WM
Nanomedicine; 2007 Mar; 3(1):75-85. PubMed ID: 17379171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
